Now the patent is another issue, as well as an announcement from the Company that they have to file with the SEC
TAUG's consultant for Corporate Finance, a management position, should tend to his business over at TAUG and leave DECN business to the company and its shareholders. In the meantime TAUG desperately needs the consultant's help. He got them into their mess and only he can get them out of it. He did it because of his jealousy of DECN CEO Berman. A resignation and his divestiture of his TAUG shares would be a good start for the consultant to take. An SEC investigation of the nonsensical TAUG news release from last week and their consultant's brush with the law can't be far behind.
As for DECN Mr. Berman, he is doing just fine. He has a unique leading edge technology now in review with the FDA. He has orders, many, many demands from people wanting to sell the product worldwide and a strong stock. Berman has everything TAUG doesn't.
Market Data 
Markets 
